· Singmed independently developed this multi-dose dual-blister DPI platform and supports bioequivalence-oriented development programs with pharmaceutical partners. The device architecture, aerosol performance and manufacturing configuration can be customized to support product development, verification and commercial-scale manufacturing.

· Inspiratory resistance range 0.04 to 0.06（kPa·s/L）